Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptives

This publication has 23 references indexed in Scilit:

• Venous thromboembolism amng new users of different oral contraceptives.
  The Lancet, 1999
• A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 μg desogestrel or 30 μg levonorgestrel
  Contraception, 1998
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  International Journal of Gynecology & Obstetrics, 1996
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995
• Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives
  Contraception, 1995
• Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel
  Contraception, 1993
• Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding
  Scandinavian Journal of Clinical and Laboratory Investigation, 1981